Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina

/PRNewswire/ -- Shanghai ZhenGe Biotech Co., Ltd. ("ZhenGe Biotech" or "the Company") announced the completion of round C financing of US $100 million, led by...

Related Keywords

China ,Lingang ,Jiangxi ,Qiming ,Sichuan ,Maryland ,United States ,Shanghai ,Zhenge ,Xizang ,Kevin Xu ,Jianxin Chen ,Amit Kakar ,Loi Xiao ,Novo Nordisk ,Contract Development ,Linkedin ,Head Of Novo Holdings Asia ,Company Board Of Directors ,Novo Group ,Rd Centers ,Manufacturing Organization ,Prnewswire Shanghai Zhenge Biotech Co Ltd ,Novo Nordisk Foundation ,Novo Holdings ,Goldman Sachs Asset Management ,Qiming Venture Capital ,Junxin Capital ,Zhenge Biotech ,Good Manufacturing Practice ,Investigational New Drug ,Antibody Drug Conjugates ,Analytical Ultra Centrifugation ,Lingang Special Area ,Pilot Free Trade Zone ,Managing Director ,China Loi Xiao Tian ,Investment Manager Lim Yizhen ,Senior Partner ,Novo Holdings Asia ,Goldman Sachs ,Euronext Brussels ,Sofina Growth ,Shanghai Zhenge Biotech Co ,Ltd ,